Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Retinal vascular occlusions
Acute retinal vascular occlusions are common causes of visual impairment. Although both
retinal artery occlusions and retinal vein occlusions are associated with increased age and …
retinal artery occlusions and retinal vein occlusions are associated with increased age and …
Anti-VEGF-resistant retinal diseases: a review of the latest treatment options
JO Wallsh, RP Gallemore - Cells, 2021 - mdpi.com
Anti-vascular endothelial growth factor (anti-VEGF) therapy currently plays a central role in
the treatment of numerous retinal diseases, most notably exudative age-related macular …
the treatment of numerous retinal diseases, most notably exudative age-related macular …
Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA)
U Schmidt-Erfurth, J Garcia-Arumi, BS Gerendas… - …, 2019 - karger.com
The high prevalence of cardiovascular disease particularly in the elderly population is
associated with retinal vascular disease. Retinal vein occlusions represent severe …
associated with retinal vascular disease. Retinal vein occlusions represent severe …
Diabetic macular oedema
Diabetic macular oedema, characterised by exudative fluid accumulation in the macula, is
the most common form of sight-threatening retinopathy in people with diabetes. It affects one …
the most common form of sight-threatening retinopathy in people with diabetes. It affects one …
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion
OBJECTIVE: To evaluate the safety and efficacy of dexamethasone intravitreal implant (DEX
implant; OZURDEX, Allergan, Inc., Irvine, CA) compared with sham in eyes with vision loss …
implant; OZURDEX, Allergan, Inc., Irvine, CA) compared with sham in eyes with vision loss …
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT study
Purpose To determine week 52 efficacy and safety outcomes in eyes with macular edema
after branch retinal vein occlusion (BRVO) treated with 2 mg intravitreal aflibercept injection …
after branch retinal vein occlusion (BRVO) treated with 2 mg intravitreal aflibercept injection …
Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study
PURPOSE: Assess 12-month efficacy and safety of intraocular injections of 0.3 mg or 0.5 mg
ranibizumab in patients with macular edema after branch retinal vein occlusion (BRVO) …
ranibizumab in patients with macular edema after branch retinal vein occlusion (BRVO) …
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results
OBJECTIVE: To evaluate the safety and efficacy of 1 or 2 treatments with dexamethasone
intravitreal implant (DEX implant) over 12 months in eyes with macular edema owing to …
intravitreal implant (DEX implant) over 12 months in eyes with macular edema owing to …
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study
Purpose To compare the efficacy and safety of intravitreal aflibercept injection (IAI) with
macular grid laser photocoagulation for the treatment of macular edema after branch retinal …
macular grid laser photocoagulation for the treatment of macular edema after branch retinal …
Natural history of branch retinal vein occlusion: an evidence-based systematic review
SL Rogers, RL McIntosh, L Lim, P Mitchell, N Cheung… - Ophthalmology, 2010 - Elsevier
OBJECTIVE: To describe the natural history of branch retinal vein occlusion (BRVO) based
on the best available evidence from the literature. CLINICAL RELEVANCE: Branch retinal …
on the best available evidence from the literature. CLINICAL RELEVANCE: Branch retinal …